Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Cpsa-CR Tablet ER

Prescription Icon
Prescription Required

Marketer

Feron Healthcare Pvt Ltd

Salt Composition

Carvedilol (10mg)

Overview Cpsa-CR Tablet ER

Extended-release Cpsa-CR tablets manage hypertension, angina pectoris, and congestive heart failure. Their mechanism involves vasodilation, improving cardiac blood flow. Reduced blood pressure contributes to stroke and myocardial infarction prevention. Administer this medication with food, adhering strictly to the prescribed dosage and regimen. Continued use is crucial, regardless of symptom presence or blood pressure readings. Discontinuation requires physician consultation to avoid potential exacerbation. Lifestyle modifications, such as regular physical activity, weight management, smoking cessation, moderated alcohol consumption, and a low-sodium diet (as directed by your physician), can enhance treatment efficacy. While generally well-tolerated, potential adverse effects include vertigo, cephalalgia, dyspnea, and fatigue. Report persistent or troublesome side effects to your doctor immediately. Prior to initiating treatment, disclose any pre-existing cardiac or renal conditions. Consult your physician before use during pregnancy or lactation.

Primary Ingredients of Cpsa-CR Tablet ER

The provided text is "undefined," so there is nothing to rephrase.

Uses of Cpsa-CR Tablet ER

Managing elevated blood pressure | Addressing angina pectoris | Cardiac insufficiency management

Major Benefits of Cpsa-CR Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Consume Cpsa-CR Tablet ER with a meal.

Common Side effects of Cpsa-CR Tablet ER:

  • Decreased blood pressure
  • Headache
  • Fatigue
  • Dizziness
  • Breathlessness

How to use Cpsa-CR Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Cpsa-CR Tablet ER with food.

How Cpsa-CR Tablet ER works:

Cpsa-CR Extended-Release tablets combine alpha and beta-blocking properties. This dual action reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Cpsa-CR Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Cpsa-CR Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Cpsa-CR tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release CPSA-CR tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Cpsa-CR tablets are considered safe for use by individuals with kidney impairment; no dosage modification is typically advised. Nevertheless, disclosure of pre-existing kidney conditions to your physician is crucial. Routine blood pressure monitoring is suggested to guide any necessary dosage alterations.

LiverLiverCAUTION

Patients with liver impairment should use Cpsa-CR Extended-Release tablets cautiously, potentially requiring dosage modification under medical supervision. Cpsa-CR Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Cpsa-CR Tablet ER :

Should you forget to take a Cpsa-CR Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cpsa-CR Tablet ER

LabelValue
Chemical Category Carbazole-propanol derivative
Developing Habits No.
Treatment Category Heart
Action Class Alpha-blocker and beta-blocker combination

FAQs on Cpsa-CR Tablet ER

Consistent use of Cpsa-CR Tablet ER, as prescribed, is crucial. Abrupt discontinuation may lead to chest pain or heart attack. Your physician will gradually reduce your dosage before complete cessation, if necessary.
Cpsa-CR Tablet ER can cause drowsiness and dizziness, especially at the start of treatment or after a dose increase. Avoid driving or operating machinery if affected.
While weight gain is a possible side effect of Cpsa-CR Tablet ER, it's not universal. If you're using Cpsa-CR Tablet ER for heart failure, report any weight gain or shortness of breath to your doctor immediately, as these could indicate fluid buildup.
Cpsa-CR Tablet ER may rarely worsen kidney function in heart failure patients. However, kidney failure risk is increased in patients with low blood pressure (systolic <100 mmHg), hardening of the arteries, pre-existing heart disease, or impaired kidney function. Close monitoring is crucial for these patients during treatment. Kidney function typically recovers after discontinuation of Cpsa-CR Tablet ER.
Diabetic patients can take Cpsa-CR Tablet ER, but require regular blood glucose monitoring. Studies show minimal impact on blood glucose in well-controlled diabetics with mild-to-moderate hypertension. However, beta-blockers like Cpsa-CR Tablet ER can mask hypoglycemic symptoms, such as increased heart rate. Furthermore, Cpsa-CR Tablet ER may worsen hyperglycemia in diabetic patients with heart failure. Therefore, close blood glucose monitoring is crucial when starting, adjusting, or stopping Cpsa-CR Tablet ER. Report any blood glucose level changes to your doctor during treatment.
Taking Cpsa-CR Tablet ER with food is recommended. Food slows absorption, minimizing the risk of orthostatic hypotension (dizziness or fainting upon standing).
CPSA-CR Tablet ER can cause serious side effects including fainting, shortness of breath, weight gain, and swelling in the extremities (arms, hands, feet, ankles, or lower legs). Other possible side effects are chest pain, irregular heartbeat, rash, hives, itching, and difficulty breathing or swallowing. Seek immediate medical attention if any of these occur.
Exceeding the recommended Cpsa-CR Tablet ER dosage can cause slowed heart rate, dizziness, fainting, breathing difficulties, vomiting, unconsciousness, or seizures. Seek immediate medical attention at a hospital and contact your doctor.
Patients with severe heart failure requiring intensive care or inotropic medications, those with asthma or breathing difficulties, bradycardia or arrhythmia, liver impairment, or a Cpsa-CR Tablet ER allergy should not use Cpsa-CR Tablet ER.
Cpsa-CR Tablet ER
111
MRP 135
17% off